These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12243661)

  • 21. [Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
    Bergman W; Rutten FF
    Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2346-50. PubMed ID: 7969635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common fungal infections of the feet in patients with diabetes mellitus.
    Tan JS; Joseph WS
    Drugs Aging; 2004; 21(2):101-12. PubMed ID: 14960127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
    Korting HC; Schöllmann C
    J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing and treating onychomycosis.
    Zaias N; Glick B; Rebell G
    J Fam Pract; 1996 May; 42(5):513-8. PubMed ID: 8642370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.
    Smith S; Houpt K; Rich P; LaMarca A; Weinberg JM; Alferez TS; Atillasoy E; Opper C
    Cutis; 2001 Jul; 68(1 Suppl):30-9. PubMed ID: 11499332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common tinea infections in children.
    Andrews MD; Burns M
    Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.
    James IG; Loria-Kanza Y; Jones TC
    J Dermatolog Treat; 2007; 18(3):163-8. PubMed ID: 17538805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral therapy for onychomycosis: an evidence-based review.
    de Sá DC; Lamas AP; Tosti A
    Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N; Shishu
    Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M; Schoellmann C; Korting HC
    Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.